Status:
UNKNOWN
The Effect of Mobile Health Applications on Symptom Control, Self-efficacy and Chronic Disease Management in COPD
Lead Sponsor:
Muş Alparslan University
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
Phase:
NA
Brief Summary
Name:The effect of the mobile application developed to provide symptom control in chronic obstructive pulmonary patients on self-efficacy and chronic disease management Aim:Considering the covid-19 p...
Detailed Description
In recent years, mobile technologies have been used in the use of self-management applications. Mobile technologies have the opportunity to provide information exchange between the patient and the hea...
Eligibility Criteria
Inclusion
- Literate
- Having and using a smartphone (Android or iPhone)
- who have been diagnosed with COPD
- no communication problem
- Not having mental confusion or any psychiatric problems
- Individuals who agree to participate in Stage 2 (50%≤FEV1\<80) and Stage 3 (30%≤FEV1\<50) and Stage 4 (FEV1\<30) research who meet the GOLD 2021 criteria will be included in the study.
Exclusion
- with cognitive dysfunction
- Comorbid diseases such as severe pulmonary, cardiological and malignant disease
- in exacerbation
- Visual, hearing, cognitive, or dexterity impairment that precludes mobile use
- Patients in Stage 1 (FEV1≥80%) meeting the GOLD 2021 criteria.
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05295901
Start Date
March 31 2022
End Date
February 15 2023
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neşe ÖZDEMİR
Muş, Turkey (Türkiye), 49000